R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Manager Market Access DACH

Business OperationsConfirmed live in the last 24 hours
Full-timeMunich, Germany€92.3k - €153.8k /yr

About the Job

Requirements

  • A university degree in health economics, natural sciences, pharmacy, medicine, business administration, or a comparable field is required.
  • Experience in Market Access and Pricing, including market access strategy development and benefit assessment dossiers.
  • Good knowledge of the German healthcare system, healthcare policy, and medicines legislation.
  • Experience handling contracts with statutory health insurance funds.
  • Ability to evaluate clinical, health economic, and market data and develop strategic recommendations.
  • Experience in oncology, hematology, neurology, rare disease, or related therapeutic areas.
  • Experience working in an international environment.
  • Excellent written and spoken German and English.
  • Strong analytical, communication, influencing, engagement, problem-solving, ownership, and strategic planning skills.

Responsibilities

  • Develop market access and pricing strategies across Germany, Austria, and Switzerland.
  • Lead dossier development under §35a SGB V, including consultations and G-BA hearings.
  • Support reimbursement price negotiations under §130b SGB V, including engagement with GKV SV.
  • Develop contracting strategies and manage rebate contract tender processes.
  • Monitor healthcare policy developments and assess portfolio implications.
  • Identify market access barriers and build tailored action plans.
  • Provide market access input to clinical development programs and evidence generation.
  • Build trusted stakeholder partnerships to advance access objectives.

Desired Qualifications

  • Experience with reimbursement price negotiations under §130b SGB V is a plus.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs